Back to search

The University of Edinburgh

Molecular mechanisms of eEF1A2-related neurodevelopmental disorder

Abstract

dc:description.abstract

The eukaryotic translation factor eEF1A2 is primarily responsible for carrying aminoacylated-tRNA to the ribosome during protein synthesis, although several secondary functions have also been reported. Mutations in the encoding gene are responsible for eEF1A2-related neurodevelopmental disorder, a rare syndrome characterised by epilepsy, intellectual disability, and developmental delay. While some individuals suffer only mild epilepsy and minor developmental delay, others experience frequent or refractory seizures, are unable to walk or speak, and are severely globally delayed. Over 50 de novo missense eEF1A2 mutations have been identified in patients, and it is hypothesised that the varying presentation is caused by different mechanisms of pathogenicity of the various mutations. The primary aim of this thesis was to investigate the mechanisms by which mutations in eEF1A2 might cause the associated symptoms, with the goal of improving available prognostic information for single cases and contributing to the development of future therapeutics. To assess the stability of mutant eEF1A2, a self-cleaving vector was used, containing wild type or variant eEF1A2 coupled by a self-cleaving peptide to the fluorescent reporter mCherry. Relative eEF1A2 expression levels were used as a putative measure of stability, and several eEF1A2 mutants were shown to be expressed at lower levels than wild type, indicating a potential decrease in stable protein, possibly resulting in a partial loss of function. Almost all associated variants are de novo and monoallelic. Therefore, if eEF1A2 syndrome can be caused by insufficient levels of functional eEF1A2, then increasing the expression of the wild-type allele of eEF1A2 may be sufficient to ameliorate symptoms. Compounds shown to increase eEF1A2 expression in myocytes (Peladeau et al., 2020) were tested for their effect on eEF1A2 expression in undifferentiated and differentiated SH-SY5Y cells, but the effects of the original study could not be replicated in neuronal model cells. A neuron-specific compound screen is required to continue this line of research. We hypothesised that individual missense mutations would differentially affect the interactome, and that the extent or nature of the changes would correlate with the severity of the phenotype. Affinity purification mass spectrometry was used to compare the interactome of wild-type and mutant eEF1A2. All variants resulted in alterations to the protein interactome. Several variants showed changes in binding to the subunits of cognate guanine exchange factor eEF1B. Additionally, several proteins associated with neurodevelopmental disorders were identified as altered interaction partners across variants, which may indicate a convergence of mechanisms for other conditions. These results indicate potential disease mechanisms, and may act as markers of pathogenicity for the classification of new or singly occurring variants. eEF1A is vital for protein synthesis, but the current literature is inconclusive about the role of eEF1A2 in different contexts, with some evidence suggesting it may even inhibit eEF1A1 when co-expressed. We hypothesised that eEF1A2 variants may negatively impact the rate of protein synthesis. HEK 293T cells were transfected with eEF1A2 variants and a puromycin-incorporation protein synthesis assay was used to measure the rate of nascent protein synthesis. Cultured mouse primary hippocampal neurons from wild-type and transgenic E122K mice were also examined. No effect of variant transfection on protein synthesis was observed, conflicting with recent findings in this field. Many eEF1A2 variants are singly occurring, so prognostic information is limited. eEF1A2 is a highly conserved gene, which acts as a confounder of successful classification of mutations by some commonly-used computational pathogenicity predictors. We identified a cohort of individuals with missense eEF1A2 variants through the UK Biobank Genome Browser, a database of predominantly healthy individuals, and hypothesised that these variants may represent either a high-confidence benign control group for training of future classifiers, or novel disease-associated eEF1A2 variants present in the population. Phenotypic information for these individuals was obtained from UK Biobank, and only one individual was noted to suffer from epilepsy. This work has established a dataset of potentially benign eEF1A2 mutations, with the intention of training a computational predictor to classify pathogenic mutations as they are newly discovered. In summary, understanding the pathophysiology of harmful eEF1A2 variants is vital for the development of future treatments of the associated disorder. Certain mutations in eEF1A2 resulted in lower expression levels in the context of transfected cells, but further work is required to identify compounds which affect eEF1A2 expression in neuronal cells. In contrast to recent findings in the literature, transient expression of eEF1A2 variants had no effect on nascent protein synthesis. However, all variants resulted in a differing interactome profile, with some variants causing changes in binding to the subunits of eEF1B, a key partner in protein synthesis. These findings point to potential disease mechanisms, and may act as markers of pathogenicity for the classification of newly discovered or singly occurring variants. Finally, a high-confidence dataset of potentially benign eEF1A2 variants was identified in UK Biobank, which may be used to train computational pathogenicity predictors to classify newly discovered variants.

Degree

thesis:*
Grantor dc:publisher
The University of Edinburgh
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Love, Heather
Advisors dc:contributor.advisor
  • Abbott, Catherine
  • Fletcher-Watson, Sue

Subjects

dc:subject × 5

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Edinburgh
Base URL
era.ed.ac.uk/server/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Love, Heather. Molecular mechanisms of eEF1A2-related neurodevelopmental disorder. The University of Edinburgh, 2025. https://hdl.handle.net/1842/43879